Skip to main content

Métastase des cellules cancéreuses : caractéristiques de l’envahissement osseux

  • Chapter
Métastases vertébrales
  • 387 Accesses

Abstrait

La métastase est définie par la capacité des cellules tumorales à quitter la tumeur primitive, à migrer et à s’implanter dans un organe à distance puis à proliférer, formant ainsi de nouveaux foyers tumoraux. La dissémination métastatique est associée à l’invasivité tissulaire locale des cellules tumorales, caractérisée par la propriété de ces cellules de pénétrer et de migrer dans les tissus normaux voisins du foyer tumoral. La métastase caractérise les tumeurs malignes (28) bien que certaines cellules normales possèdent cette même capacité à quitter leur tissu d’origine. Ces phénomènes de migration cellulaire sont observés par exemple chez l’embryon au cours de la migration des cellules vers le thymus ou chez l’adulte lors bryon d’une réaction immunitaire au cours de la migration et prolifération de cellules lymphomonocytaires dans les ganglions. Cependant, ces événements physiologiques ou physiopathologiques qui aboutissent à la prolifération de cellules tissent normales dans des sites particuliers obéissent à des signaux d’arrêt de prolifération stricts, liés le plus souvent à la différenciation ou à l’apoptose des cellules concernées. Les cellules tumorales échappent à ces contrôles, prolifèrent dans les organes atteints, formant des foyers secondaires, souvent multiples.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. An Z, Wang X, Willmott N, Chander SK, Tickle S, Docherty AJ, Mountain A, Millican AT, Morphy R, Porter JR, Epemolu RO, Kubota T, Moossa AR, Hoffman RM (1997) Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor. Clin Exp Metastasis 15: 184–95.

    Article  PubMed  CAS  Google Scholar 

  2. Anzai H, Kitadai Y, Bucana CD, Sanchez R, Omoto R, Fidler IJ (1996) Intratumoral heterogeneity and inverse correlation between expression of E-cadherin and collagenase type IV in hum cadherin human gastric carcinomas. Differentiation 60: 119–27.

    Article  PubMed  CAS  Google Scholar 

  3. Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer OL, Chenard MP, Rio MC, Chambon P (1990) A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348: 699–704.

    Article  PubMed  CAS  Google Scholar 

  4. Bellahcene A, Kroll M, Liebens F, Castronovo V (1996) Bone sialoprotein expression in primary human breast cancer is associated with bone metastases development. J Bone Miner Res 11: 665–70.

    Article  PubMed  CAS  Google Scholar 

  5. Boudreau N, Andrews C, Srebrow A, Ravanpay A, Cheresh DA (1997) Induction of the angiogenic phenotype by Hox D3. J Cell Biol 139: 257–64.

    Article  PubMed  CAS  Google Scholar 

  6. Brooks PC, Stromblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP, Cheresh DA (1996) Localization of matrix metallo-proteinase MMP-2 to the surface of invasive cells by interaction with integrin proteinase alpha v beta 3. Cell 85: 683–93.

    Article  PubMed  CAS  Google Scholar 

  7. Care A, Silvani A, Meccia E, Mattia G, Stoppacciaro A, Parmiani G, Peschle C, Colombo MP (1996) HOXB7 constitutively activates basic fibroblast growth factor in melanomas. Mol Cell Biol 16: 4842–51.

    PubMed  CAS  Google Scholar 

  8. Chekmareva MA, Kadkhodaian MM, Hollowell CM, Kim H, Yoshida BA, Luu HH, Stadler WM, Rinker-Schaeffer CW (1998) Chromosome 17-mediated dormancy of AT6.1 prostate cancer micrometastases. Cancer Res 58: 4963–9.

    PubMed  CAS  Google Scholar 

  9. Chen D, Ji X, Harris MA, Feng JQ, Karsenty G, Celeste AJ, Rosen V, Mundy GR, Harris SE (1998) Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. J Cell Biol 142: 295–305.

    Article  PubMed  CAS  Google Scholar 

  10. Dutrillaux B, Gerbault-Seureau M, Zafrani B (1990) Characterization of chromosomal anomalies in human breast cancer. A comparison of 30 paradiploid cases with few chromosome changes. Cancer Genet Cytogenet 49: 203–17.

    Article  PubMed  CAS  Google Scholar 

  11. Fidler IJ (1994) Therapy of cancer metastasis by systemic activation of macrophages. Adv Pharmacol 30: 271–326.

    PubMed  CAS  Google Scholar 

  12. Folkman J (1997) Angiogenesis and angiogenesis inhibition: an overview. EXS 79: 1–8.

    PubMed  CAS  Google Scholar 

  13. Frisch SM, Vuori K, Ruoslahti E, Chan-Hui PY (1996) Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol 134: 793–9.

    Article  PubMed  CAS  Google Scholar 

  14. Goldie JH (1994) Modelling the process of drug resistance. Lung Cancer 10(Suppl 1): S91–S96.

    Article  PubMed  Google Scholar 

  15. Goldie JH, Coldman AJ (1979) A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63: 1727–33.

    PubMed  CAS  Google Scholar 

  16. Greene GF, Kitadai Y, Pettaway CA, von Eschenbach AC, Bucana CD, Fidler IJ (1997) Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique. Am J Pathol 150: 1571–82.

    PubMed  CAS  Google Scholar 

  17. Gunthert U, Hofmann M, Rudy W, Reber S, Zoller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65: 13–24.

    Article  PubMed  CAS  Google Scholar 

  18. Hill RP, Chambers AF, Ling V, Harris JF (1984) Dynamic heterogeneity: rapid generation of metastatic variants in mouse B16 melanoma cells. Science 224: 998–1001.

    Article  PubMed  CAS  Google Scholar 

  19. Jouanneau J, Moens G, Bourgeois Y, Poupon MF, Thiery JP (1994) A minority of carcinoma cells producing acidic fibroblast growth factor induces a community effect for tumor progression. Proc Natl Acad Sci USA 91: 286–90.

    Article  PubMed  CAS  Google Scholar 

  20. Kuo TH, Kubota T, Watanabe M, Furukawa T, Teramoto T, Ishibiki K, Kitajima M, Moossa AR, Penman S, Hoffman RM (1995) Liver colonization competence governs colon cancer metastasis. Proc Natl Acad Sci USA 92: 12085–9.

    Article  PubMed  CAS  Google Scholar 

  21. Kuramochi H, Ichikawa T, Nihei N, Kawana Y, Suzuki H, Schalken JA, Takeichi M, Nagafuchi A, Ito H, Shimazaki J (1997) Suppression of invasive ability of highly metastatic rat prostate cancer by introduction of human chromosome 8. Prostate 31: 14–20.

    Article  PubMed  CAS  Google Scholar 

  22. Lane DP (1992) Cancer. p53, guardian of the genome. Nature 358: 15–6.

    Article  PubMed  CAS  Google Scholar 

  23. Luria S, Delbrück M (1943) Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28: 491–511.

    PubMed  CAS  Google Scholar 

  24. Mareel M, Boterberg T, Noe V, Bruyneel E, Bracke M (1996) Molecular aspects of cancer metastasis: extracellular regulation of the E-cadherin/catenin complex. Int J Dev Biol (Suppl 1): 65S–66S.

    Google Scholar 

  25. Mareel M, Vleminckx K, Vermeulen S, Yan G, Bracke M, van Roy F (1994) Downregulation in vivo of the invasion-suppressor molecule E-cadherin in experimental and clinical cancer. Princess Takamatsu Symp 24: 63–80.

    PubMed  CAS  Google Scholar 

  26. Mundy GR (1996) Regulation of bone formation by bone morphogenetic proteins and other growth factors. Clin Orthop 24–8.

    Google Scholar 

  27. Mundy GR (1997) Mechanisms of bone metastasis. Cancer 80: 1546–56.

    Article  PubMed  CAS  Google Scholar 

  28. Paget S (1989) The distribution of secondary growths in cancer of the breast. Cancer Metastasis Rev 8: 98–101

    PubMed  CAS  Google Scholar 

  29. Patterson BC, Sang QA (1997) Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J Biol Chem 272: 28823–5.

    Article  PubMed  CAS  Google Scholar 

  30. Poupon MF (1990) L’évolution des tumeurs malignes. Pour la Science 149: 72–7.

    Google Scholar 

  31. Richmond PJ, Karayiannakis AJ, Nagafuchi A, Kaisary AV, Pignatelli M (1997) Aberrant E-cadherin and alpha-catenin expression in prostate cancer: correlation with patient survival. Cancer Res 57: 3189–93

    PubMed  CAS  Google Scholar 

  32. Silletti S, Timar J, Honn KV, Raz A (1994) Autocrine motility factor induces differential 12-lipoxygenase expression and activity in high-and low-metastatic K1735 melanoma cell variants. Cancer Res 54: 5752–6.

    PubMed  CAS  Google Scholar 

  33. Singh RK, Fidler IJ (1996) Regulation of tumor angiogenesis by organ-specific cytokines. Curr Top Microbiol Immunol 213: 1–11.

    PubMed  CAS  Google Scholar 

  34. Skoudy A, Llosas MD, Garcia DH (1996) Intestinal HT-29 cells with dysfunction of E-cadherin show increased pp60src activity and tyrosine phosphorylation of p120-catenin. Biochem J 317: 279–84.

    PubMed  CAS  Google Scholar 

  35. Takeichi M (1988) The cadherins: cell-c cell adhesion molecules controlling animal morphogenesis. Development 102: 639–655.

    PubMed  CAS  Google Scholar 

  36. Tiberio C, Barba P, Magli MC, Arvelo F, Le Chevalier T, Poupon MF, Cillo C (1994) HOX gene expression in human small-cell lung cancers xenografted into nude mice. Int J Cancer 58: 608–15.

    Article  PubMed  CAS  Google Scholar 

  37. Van Hengel J, Gohon L, Bruyneel E, Vermeulen S, Cornelissen M, Mareel M, von Roy F (1997) Protein kinase C activation upregulates intercellular adhesion of alpha-catenin-negative human colon cancer cell variants via induction of desmosomes. J Cell Biol 137: 1103–16.

    Article  PubMed  Google Scholar 

  38. Vandenbunder B, Wernert N, Queva C, Desbiens X, Stehelin D (1994) Does the transcription factor c-ets1 take part in the regulation of angiogenesis and tumor invasion ? Folia Biol (Praha) 40: 301–13.

    CAS  Google Scholar 

  39. Weiss L (1985) Principles of metastasis. New York, Academic Press.

    Google Scholar 

  40. Yebra M, Parry GCN, Stromblad S, Mackman N, Rosenberg S, Mueller BM, Cheresh DA (1996) Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migration. J Biol Chem 271: 29393–9.

    Article  PubMed  CAS  Google Scholar 

  41. Yin JJ, Selander K, Chirgwin JM, Dallas M, Grubbs BG, Wieser R, Massague J, Mundy GR, Guise TA (1999) TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J Clin Invest 103: 197–206.

    PubMed  CAS  Google Scholar 

  42. Yoneda T, Sasaki A, Dunstan C, Williams PJ, Bauss F, De Clerck YA, Mundy GR (1997) Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2. J Clin Invest 99: 2509–17.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Poupon, MF. (2007). Métastase des cellules cancéreuses : caractéristiques de l’envahissement osseux. In: Pointillart, V., Ravaud, A., Palussière, J. (eds) Métastases vertébrales. Springer, Paris. https://doi.org/10.1007/978-2-287-33744-4_3

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-33744-4_3

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-33743-7

  • Online ISBN: 978-2-287-33744-4

Publish with us

Policies and ethics